Pharmacology Review: Use of Inhaled Nitric Oxide in the Preterm Infant

Studies have shown that inhaled nitric oxide (iNO) improves ventilation/perfusion matching, decreases lung inflammation and oxidant stress, and restores more normal patterns of angiogenesis and parenchymal growth in the immature lung. Such findings suggest a potential role for this therapy in preterm newborns at risk for bronchopulmonary dysplasia. Early clinical trials have shown that iNO can benefit larger preterm infants (>1,000 g) who have early respiratory failure and preterm infants who continue to require positive pressure support after the first postnatal week. Debate continues as to whether iNO increases the rate of intracerebral hemorrhage. Additional trials are needed to discern benefits to specific forms and durations of iNO therapy in both the short and long term.

[1]  M. Walsh,et al.  Inhaled nitric oxide in preterm infants undergoing mechanical ventilation. , 2006, The New England journal of medicine.

[2]  G. Cutter,et al.  Early inhaled nitric oxide therapy in premature newborns with respiratory failure. , 2006, The New England journal of medicine.

[3]  S. Abman,et al.  Inhaled NO restores lung structure in eNOS-deficient mice recovering from neonatal hypoxia. , 2006, American journal of physiology. Lung cellular and molecular physiology.

[4]  M. Gladwin,et al.  Inhaled nitric oxide decreases infarction size and improves left ventricular function in a murine model of myocardial ischemia-reperfusion injury. , 2006, American journal of physiology. Heart and circulatory physiology.

[5]  R. Savani,et al.  Surfactant Composition and Function in a Primate Model of Infant Chronic Lung Disease: Effects of Inhaled Nitric Oxide , 2006, Pediatric Research.

[6]  D. Carlton,et al.  Inhaled nitric oxide effects on lung structure and function in chronically ventilated preterm lambs. , 2005, American journal of respiratory and critical care medicine.

[7]  J. Marks,et al.  Neurodevelopmental outcomes of premature infants treated with inhaled nitric oxide. , 2005, The New England journal of medicine.

[8]  W. Poole,et al.  Inhaled nitric oxide for premature infants with severe respiratory failure. , 2005, The New England journal of medicine.

[9]  S. Abman,et al.  Inhaled Nitric Oxide Enhances Distal Lung Growth after Exposure to Hyperoxia in Neonatal Rats , 2005, Pediatric Research.

[10]  J. Stocks,et al.  Neonatal Ventilation With Inhaled Nitric Oxide Versus Ventilatory Support Without Inhaled Nitric Oxide for Preterm Infants With Severe Respiratory Failure: The INNOVO Multicentre Randomised Controlled Trial (ISRCTN 17821339) , 2005, Pediatrics.

[11]  G. Thiriez,et al.  The safety and efficacy of nitric oxide therapy in premature infants. , 2005, The Journal of pediatrics.

[12]  J. Crapo,et al.  Inhaled NO improves early pulmonary function and modifies lung growth and elastin deposition in a baboon model of neonatal chronic lung disease. , 2005, American journal of physiology. Lung cellular and molecular physiology.

[13]  S. Abman,et al.  Inhaled nitric oxide attenuates pulmonary hypertension and improves lung growth in infant rats after neonatal treatment with a VEGF receptor inhibitor. , 2004, American journal of physiology. Lung cellular and molecular physiology.

[14]  J. Marks,et al.  Inhaled nitric oxide in premature infants with the respiratory distress syndrome. , 2003, The New England journal of medicine.

[15]  N. Shaw,et al.  Neurodevelopmental outcome in high‐risk preterm infants treated with inhaled nitric oxide , 2001, Acta paediatrica.

[16]  B. Thébaud,et al.  Early compared with delayed inhaled nitric oxide in moderately hypoxaemic neonates with respiratory failure: a randomised controlled trial , 1999, The Lancet.

[17]  D. Cornfield,et al.  Inhaled nitric oxide in premature neonates with severe hypoxaemic respiratory failure: a randomised controlled trial , 1999, The Lancet.

[18]  S. Ryan,et al.  Open randomised controlled trial of inhaled nitric oxide and early dexamethasone in high risk preterm infants , 1997, Archives of disease in childhood. Fetal and neonatal edition.